rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michel Detheux

Director

Company insider

Files Form 4 as: Director, Vor Biopharma; Chief Executive Officer, iTeos Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
118
Buys
0
Sells
30
Bought
$0
Sold
$10.0M
Companies
2
Companies where not an officer
1
First trade
23 Jul 2020
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
iTeos TherapeuticsDirector, Officer · last 29 Aug 20250 buys · 30 sells
Everywhere else they filed: board seats, 10% stakes, other companies
VOR Vor BiopharmaDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
50Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—57,162 at $0.00filing
11 Jun 2026filed 12 Jun 2026VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—57,162 at $0.00filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—14,185filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—444,815filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—94,336filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—50,128filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—17,544filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—185,000filing
29 Aug 2025filed 29 Aug 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code D—52,700filing
29 Aug 2025filed 29 Aug 2025iTeos TherapeuticsSEC FORM 4 Code U—153,903filing
29 Aug 2025filed 29 Aug 2025iTeos TherapeuticsSEC FORM 4 Code U—94,027filing
16 Jul 2025filed 18 Jul 2025VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
10 Jun 2025filed 11 Jun 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code M—8,400 at $0.00filing
10 Jun 2025filed 11 Jun 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code M—43,883 at $0.00filing
10 Jun 2025filed 11 Jun 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code M—18,000 at $0.00filing
10 Jun 2025filed 11 Jun 2025iTeos Therapeuticsoption or derivativeSEC FORM 4 Code M—94,027 at $0.00filing
10 Jun 2025filed 11 Jun 2025iTeos TherapeuticsSEC FORM 4 Code M$36K8,400 at $4.30filing
10 Jun 2025filed 11 Jun 2025iTeos TherapeuticsSEC FORM 4 Sold$84K8,400 at $10.02filing
10 Jun 2025filed 11 Jun 2025iTeos TherapeuticsSEC FORM 4 Code M$189K43,883 at $4.30filing
10 Jun 2025filed 11 Jun 2025iTeos TherapeuticsSEC FORM 4 Sold$440K43,883 at $10.02filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed30

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.